iXCells Biotechnologies

iXCells Biotechnologies' Preclinical Services

iXCells Biotechnologies offers a comprehensive suite of preclinical services designed to support innovative research and development in biotechnology and pharmaceuticals. Their services include iPSC (induced pluripotent stem cell) solutions, genome editing using advanced Cas9 technology, and a variety of in vitro assays. These services enable researchers to explore new therapeutic avenues and accelerate the drug discovery process. By providing customizable models for disease research, iXCells Biotechnologies ensures that scientists can tailor their studies to their specific needs, enhancing the precision and relevance of their findings.

iXCells Biotechnologies' Product Range

iXCells Biotechnologies provides an extensive range of products essential for cutting-edge research in the life sciences. Their catalog includes human and animal primary cells, iPSC-derived cells, and specialized cell media and reagents. Additionally, they offer growth factors and cytokines that are crucial for cell culture and experimentation. These products are meticulously designed to support high-quality research and are widely used in various fields, including disease modeling, drug screening, and regenerative medicine. The availability of customizable models further allows researchers to adapt their studies to specific experimental needs, thereby ensuring more accurate and meaningful results.

iXCells Biotechnologies' CRO Services

As a Contract Research Organization (CRO), iXCells Biotechnologies provides a range of preclinical services tailored to meet the diverse needs of their clients. Their offerings include iPSC reprogramming, Cas9 genome editing, directed differentiation, and custom cell isolation. Additionally, they specialize in in vitro assays and ASO (antisense oligonucleotide) screening. These services are designed to facilitate high-throughput screening and detailed mechanistic studies, enabling researchers to gain deeper insights into cellular functions and disease mechanisms. By leveraging their expertise in complex assay development and execution, iXCells Biotechnologies supports the advancement of scientific research and drug development.

iXCells Biotechnologies' Complex Assay Development

iXCells Biotechnologies excels in the development and execution of complex assays, which are critical for supporting advanced research endeavors. Their capabilities include building multi-cellular models and conducting compound screening for iPSC-derived neurons and human immune cells. These sophisticated assays allow for a more comprehensive understanding of cellular interactions and the effects of various compounds on different cell types. By providing detailed and accurate assay results, iXCells Biotechnologies helps researchers identify promising therapeutic candidates and elucidate the underlying mechanisms of diseases. This expertise is particularly valuable in fields such as neuroscience, immunology, and oncology.